GALA RENEE D 4

What Happened
Gala Renee D., President & CEO of Jazz Pharmaceuticals (JAZZ), had 4,835 shares withheld to satisfy tax obligations arising from the vesting of previously granted restricted stock units. The withholding covered shares valued at $237.72 each, for a total value of approximately $1,149,376. This was a tax-withholding disposition (code F), not an open-market sale or new purchase.

Key Details

• Transaction date: 2026-06-30
• Price per share: $237.72; total value of withheld shares: ~$1,149,376
• Transaction type/code: F — shares withheld to satisfy tax obligations on vested RSUs
• Shares owned after transaction: not specified in the Form 4 filing
• Footnote: F1 — shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units
• Filing: Reported on the Form 4 filed 2026-07-02 (appears timely under standard two-business-day filing rules)

Context
Tax-withholding by surrendering or withholding shares is a routine administrative action when RSUs vest; it is not an open-market sale and therefore less informative about the insider’s market view. For investors tracking insider activity, purchases are generally more meaningful as bullish signals; withholding for taxes is typically neutral and reflects compensation tax settlement rather than a decision to liquidate holdings.